GEHC Stock Declines Due to Tariff Impact

Author's Avatar
Apr 03, 2025

Shares of GE HealthCare Technologies (GEHC, Financial) experienced a significant decline, dropping by 9.53% today. The movement in stock price is attributed to the company's vulnerability to U.S. tariff policies, which have put additional pressure on its global operations.

GE HealthCare Technologies Inc. (GEHC, Financial) is a prominent player in the healthcare equipment sector. In 2024, the company reported revenues of $19.7 billion, with $9 billion coming from North America and $10.7 billion from international markets, including $2.4 billion from China. The company operates in a competitive space alongside major firms like Siemens Healthineers and Philips Healthcare.

The imposition of tariffs has impacted GEHC in two significant ways. Retaliatory tariffs and trade conflicts can hinder its international competitiveness, and rising tariffs can increase costs for products imported from countries such as Mexico or Canada. The company had previously incorporated existing tariffs into its annual financial outlook, yet unforeseen increases, such as the jump in Chinese tariffs from 10% to 54%, present an ongoing challenge.

Despite these hurdles, GE HealthCare Technologies maintains a strong market presence. The company's PE ratio of 16.58 and PB ratio of 3.89 are near their two-year lows, signaling potential value for investors. However, the Altman Z-score of 1.86 indicates financial stress, placing GEHC in a grey area of financial health.

From a valuation perspective, the company's GF Value is not available for a detailed assessment, yet the current market capitalization stands at $32.8 billion. The firm's EBITDA margin of 18.67% shows a favorable profitability aspect, while a dividend yield near a two-year high reflects a commitment to returning value to shareholders.

GE HealthCare's reliance on developed economies' demand and emerging markets' growth is critical for future stability. The company's expanding dividend and a strong competitive stance in the U.S. market, despite tariff-related challenges, might provide a foundation for recovery.

Disclosures

I/We may personally own shares in some of the companies mentioned above. However, those positions are not material to either the company or to my/our portfolios.